Education
About Us
Working with TipRanks
Follow Us
BioHarvest Sciences (BHST)
NASDAQ:BHST
BHST Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.66 - $9.90
Previous CloseN/A
VolumeN/A
Average Volume (3M)15.03K
Market Cap
$151.32M
Enterprise Value$172.80M
Total Cash (Recent Filing)$3.73M
Total Debt (Recent Filing)$21.09M
Price to Earnings (P/E)―
Beta0.53
Next Earnings
Dec 01, 2025EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding17,333,430
10 Day Avg. Volume21,686
30 Day Avg. Volume15,034
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.14
Enterprise Value/Revenue5.73
Enterprise Value/Gross Profit9.87
Enterprise Value/Ebitda-29.69
Forecast
1Y Price Target
$12.63Price Target Upside44.67% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Product DiversificationThe company is expecting revenue contribution from five products by the end of 2025, demonstrating product expansion and diversification.
Revenue GrowthBioHarvest Sciences Inc. reported revenues of $7.9M, showing a 47% year-over-year increase, indicating strong growth.
Strategic PartnershipsBioHarvest has signed CDMO contracts with three partners, including Tate & Lyle PLC, indicating strategic growth in the pharmaceutical and other industries.
Bears Say
Capital Raising NeedsThe company may need to raise capital before the end of 1Q25 to pay down its convertible loans and fund operations for 1H25.
Revenue GuidanceThe 3Q25 revenue guidance is below prior consensus and previous estimates.
Revenue Guidance MissManagement introduced 2Q25 revenue guidance of at least $8.5M, up 41.0% y/y, but below prior consensus of $8.9M, and our prior estimate of $9.2M.
BioHarvest Sciences News
BHST FAQ
What was BioHarvest Sciences’s price range in the past 12 months?
BioHarvest Sciences lowest stock price was $4.66 and its highest was $9.90 in the past 12 months.
What is BioHarvest Sciences’s market cap?
BioHarvest Sciences’s market cap is $151.32M.
When is BioHarvest Sciences’s upcoming earnings report date?
BioHarvest Sciences’s upcoming earnings report date is Dec 01, 2025 which is in 97 days.
How were BioHarvest Sciences’s earnings last quarter?
BioHarvest Sciences released its earnings results on Aug 11, 2025. The company reported -$0.24 earnings per share for the quarter, missing the consensus estimate of -$0.11 by -$0.13.
Is BioHarvest Sciences overvalued?
According to Wall Street analysts BioHarvest Sciences’s price is currently Undervalued.
Does BioHarvest Sciences pay dividends?
BioHarvest Sciences does not currently pay dividends.
What is BioHarvest Sciences’s EPS estimate?
BioHarvest Sciences’s EPS estimate is -0.12.
How many shares outstanding does BioHarvest Sciences have?
BioHarvest Sciences has 17,333,430 shares outstanding.
What happened to BioHarvest Sciences’s price movement after its last earnings report?
BioHarvest Sciences reported an EPS of -$0.24 in its last earnings report, missing expectations of -$0.11. Following the earnings report the stock price went up 0.685%.
Which hedge fund is a major shareholder of BioHarvest Sciences?
Currently, no hedge funds are holding shares in BHST
BioHarvest Sciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.63 (44.67% Upside)
$12.63 (44.67% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
61.36%
12-Months-Change
Fundamentals
Return on Equity
-973.22%
Trailing 12-Months
Asset Growth
2.90%
Trailing 12-Months
Company Description
BioHarvest Sciences
BioHarvest Sciences (BHST) is a biotechnology company that specializes in the development and commercialization of proprietary biofarming technology. This technology is designed to produce active plant ingredients without the need to grow the entire plant. The company's core products are based on biofarming platforms that enable the sustainable production of plant-based compounds for the nutraceutical and pharmaceutical sectors.
BHST Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth, gross margin expansion, and success in both product and CDMO divisions, indicating strong operational momentum. However, increased operating expenses and net losses present challenges. The launch of new products and strategic programs, such as the Health Pros' Affiliate program, are positive indicators for future growth.View all BHST earnings summariesBHST Stock 12 Month Forecast
Average Price Target
$12.63
▲(44.67% Upside)
Technical Analysis
Ownership Overview
Options Prices
Currently, No data available
---